ADD ANI AS A TRUSTED SOURCE
googleads
Menu

      
      COVID-19: Health ministry decides not to put Itolizumab in...

COVID-19: Health ministry decides not to put Itolizumab in...

New Delhi, July 26 (ANI): Even as the Drugs Controller General of India (DCGI) has given permission to Itolizumab...

      
      COVID-19: DCGI nod to Jubilant Generics to manufacture, sell...

COVID-19: DCGI nod to Jubilant Generics to manufacture, sell...

New Delhi [India], July 20 (ANI): The Drug Controller General of India (DCGI) has granted permission to pharma...

      
      FDA issues first emergency use authorisation for COVID-19...

FDA issues first emergency use authorisation for COVID-19...

Washington D.C. [USA], July 19 (ANI): The US Food and Drug Administration (FDA) on Saturday (local time) issued...


      
      Biocon's drug Itolizumab gets DCGI nod for use in moderate to...

Biocon's drug Itolizumab gets DCGI nod for use in moderate to...

Bengaluru (Karnataka) [India], July 11 (ANI): Biopharmaceutical major Biocon Ltd said on Saturday it has received...

      
      DCGI approves Itolizumab injection for restricted emergency...

DCGI approves Itolizumab injection for restricted emergency...

New Delhi [India], July 11 (ANI): The Drug Controller General of India (DCGI) granted its permission to...


      
      DCGI gives nod to Mylan labs to manufacture remdesivir for...

DCGI gives nod to Mylan labs to manufacture remdesivir for...

New Delhi [India], July 2 (ANI): The Drug Controller General of India (DCGI) has granted permission to Mylan...

      
      Domestic pharma giants-- Cipla, Hetero got DCGI's nod to...

Domestic pharma giants-- Cipla, Hetero got DCGI's nod to...

New Delhi [India], June 21 (ANI): In a significant development, India's top drug regulator has given nod to two...

      
      Anti-viral drug favipiravir gets DGCI nod for 'restricted...

Anti-viral drug favipiravir gets DGCI nod for 'restricted...

New Delhi [India], June 19 (ANI): The Drug Controller General of India (DCGI) has granted permission to anti-viral...

      
      US left with 63 million doses of anti-malarial drug after FDA...

US left with 63 million doses of anti-malarial drug after FDA...

Washington D.C. [USA], June 19 (ANI): The US federal government is now left with 63 million doses of...


      
      US FDA revokes emergency authorisation for HCQ championed by...

US FDA revokes emergency authorisation for HCQ championed by...

Washington D.C. [US], June 15 (ANI): The US Food and Drug Administration (FDA) on Monday revoked the emergency use...

      
      Remdesivir included in 'investigational therapy' for...

Remdesivir included in 'investigational therapy' for...

New Delhi [India], June 14 (ANI): Union Health Ministry on Sunday said that drug Remdesivir has been included as an...

      
      India to soon begin domestic production of Remdesivir drug to...

India to soon begin domestic production of Remdesivir drug to...

New Delhi [India], June 13 (ANI): India is soon going to have its domestic production of anti-viral Remdesivir drug,...
Home About Us Our Products Advertise Contact Us Terms & Condition Privacy Policy

Copyright © aninews.in | All Rights Reserved.